Tiptree Q2 2026: Fortegra Sale Closes, $372M Gain Drives $10.38 EPS; Cash Pile Hits $947M, New $20M Buyback Authorized
TIPT sits 18% above its 52-week low of $15.49.
Summary
Tiptree reported Q2 2026 net income of $389.2M ($10.38 diluted EPS) driven by the $372.2M after-tax gain on the Fortegra sale. Cash and equivalents surged to $946.9M, and the board authorized a new $20M share repurchase program.
Key Events · Earnings and Guidance · TIPT
-
Fortegra Sale Closes, $372M Gain
The $1.65B sale of Fortegra closed May 29, 2026, generating a $372.2M after-tax gain. Tiptree received $1.12B in net cash proceeds for its 69% stake.
-
Q2 EPS of $10.38 on Discontinued Ops
Diluted EPS was $10.38, driven entirely by the Fortegra gain and discontinued operations. Continuing operations lost $6.4M ($0.17 per share).
-
Cash Pile Hits $946.9M, Zero Debt
Cash and equivalents rose to $946.9M from $30.8M at year-end 2025. All holding company debt was repaid from sale proceeds. Current tax payable of $204.8M is the only significant liability.
-
New $20M Buyback Authorized
On July 28, 2026, the board authorized a new $20M share repurchase program, replacing the prior authorization. 614,103 shares were repurchased in H1 2026 at an average price of $16.80.
Analysis · TIPT · Finance
Tiptree's Q2 2026 10-Q marks the completion of its transformation. The $1.65B Fortegra sale closed May 29, generating a $372.2M after-tax gain that produced diluted EPS of $10.38. The balance sheet is now fortress-like: $946.9M in cash and equivalents, zero debt, and stockholders' equity of $907.1M ($24.34 per share). Continuing operations remain a loss-making corporate shell ($6.4M loss), but the company has already deployed capital — a new $20M buyback was authorized July 28, and a $100M acquisition of Universal Shield Insurance Group was announced the same day. The market will now focus on how management allocates the remaining ~$800M+ in net cash.
At the time of this filing, TIPT was trading at $18.29 on NASDAQ in the Finance sector, with a market capitalization of approximately $678.1M. The 52-week trading range was $15.49 to $27.41. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.